Tirzepatide 45MG
$140.00
Tirzepatide 45MG is a 45-milligram format of tirzepatide, a synthetic peptide analogue engineered from incretin hormone motifs. Researchers study tirzepatide for its potential activity at incretin receptor pathways and for how such signaling may relate to metabolic regulation in preclinical and clinical research contexts.
In Stock
Tirzepatide 45MG is a 45-milligram format of tirzepatide, a synthetic dual incretin receptor peptide designed to mimic aspects of endogenous incretin hormones. It is investigated in research settings where peptide agonism at incretin receptors is examined alongside downstream signaling, pharmacology, and biomarker readouts.
Studies have examined tirzepatide in the context of glucose homeostasis, energy balance, and cardiometabolic endpoints, typically using controlled experimental models and clinical study designs. Tirzepatide 45MG may be used as a reference material in method development and receptor pathway research where defined peptide identity is required.
- Specification: 45MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Semaglutide 15MG is a 15-milligram format of semaglutide, a synthetic peptide analogue of the endogenous incretin hormone GLP 1. Researchers study semaglutide as a GLP 1 receptor agonist in models of glucose regulation, appetite signaling, and cardiometabolic physiology.
In Stock
Semaglutide 2MG is a 2-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied in pharmacology and metabolic research as a long acting incretin mimetic. Researchers examine semaglutide in receptor signaling and glucose homeostasis models.
In Stock
Cagrilintide 5MG is a 5-milligram format of cagrilintide, a long acting amylin analogue peptide engineered for extended receptor activity. Researchers study amylin analogues in the context of metabolic signaling, appetite regulation pathways, and gastric emptying models.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Trenbolone Enanthate 125Mg; Drostanolone Enanthate 125Mg; Testosterone Enanthate 125Mg – 500mg/ml, 10ml is a multi compound anabolic androgenic steroid preparation featuring three long ester derivatives of trenbolone, drostanolone, and testosterone. Researchers may reference this combination when examining androgen receptor driven signaling, ester linked pharmacokinetics, and analytical detection methods in complex steroid mixtures. Studies have also considered how mixed esterified steroids behave in chromatography and mass spectrometry workflows.
In Stock
Trenbolone Acetate (Tra) 100mg/ml 10ml is a specified concentration and volume format of trenbolone acetate, an acetate ester of trenbolone and a synthetic anabolic androgenic steroid. Researchers may reference trenbolone acetate in studies involving androgen receptor signaling, steroid ester pharmacokinetics, and analytical method development. It is also encountered in forensic and anti doping research workflows focused on steroid identification.
In Stock
Trenbolone Acetate 75Mg; Trenbolone Enanthate 75Mg; Trenbolone Hexahydrobenzylcarbonate (Parabolan) 75Mg – 200mg/ml, 10 ml is a multi ester trenbolone preparation specified at 200 mg per mL in a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from 19 nortestosterone, and researchers may use it when studying androgen receptor signaling and steroid structure activity relationships. Work in preclinical and analytical settings has examined trenbolone esters for differences in lipophilicity, hydrolysis rates, and detection profiles.
In Stock
Semaglutide 10MG is a 10-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. Researchers study semaglutide in receptor pharmacology and metabolic signaling research, including models examining appetite regulation and glucose homeostasis. It is also used in assay development and method validation where GLP 1 pathway engagement is of interest.
In Stock
Trenbolone Base 50mg ml 10ml refers to trenbolone in a 50 mg per mL concentration across a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from the 19 nor testosterone scaffold. Researchers have used trenbolone as a reference compound in studies involving androgen receptor signaling and anabolic steroid structure activity relationships.
In Stock
Cagrilintide + Semaglutide 10MG is a 10-milligram peptide pair combining cagrilintide, an amylin analogue, with semaglutide, a GLP-1 receptor agonist peptide. Researchers study these peptides in metabolic research, including appetite signaling and glucose regulation pathways. This paired format is used in experimental designs that examine co-agonism and complementary endocrine signaling.
In Stock
Tirzepatide 30MG is a 30-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glucose regulation pathways, and energy balance models.
In Stock
Semaglutide 30MG is a 30-milligram format of semaglutide, a synthetic GLP-1 receptor agonist peptide analogue. Researchers study semaglutide in the context of incretin signaling, glucose regulation pathways, and appetite related neuroendocrine models. It is a modified peptide designed to extend stability relative to native GLP-1.
In Stock
